Dr. Kremer et al reply

J Rheumatol. 2022 Mar;49(3):338-339. doi: 10.3899/jrheum.210992. Epub 2021 Oct 15.

Authors

Joel M Kremer¹, George Reed², Dimitrios A Pappas³, Kevin Kane², Vivi L Feathers⁴, Michael E Weinblatt⁴, Nancy Shadick⁴, Jeffrey Greenberg⁵, Leslie L Harrold²

Affiliations

¹ Albany Medical College, Albany, New York; jkremer@corrona.org.
² University of Massachusetts School of Medicine, Worcester, Massachusetts.
³ Columbia University College of Physicians and Surgeons, New York, New York.
⁴ Brigham and Women's Hospital, Boston, Massachusetts.
⁵ New York University School of Medicine, New York, New York, USA.

PMID: 34654733
DOI: 10.3899/jrheum.210992

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Arthritis, Rheumatoid*
Humans
Methotrexate

Substances

Methotrexate